Search clinical trials for: Bevasiranib

Total 5 results

OPKO Health, Inc.

Completed

Safety and Efficacy Study of Small Interfering RNA Molecule (Cand5) to Treat Diabetic Macular Edema

Diabetic Macular Edema

United States
OPKO Health, Inc.

Completed

Safety and Efficacy Study of Small Interfering Ribonucleic Acid (RNA) Molecule (Cand5) to Treat Wet Age-Related Macular Degeneration

Macular Degeneration

United States
OPKO Health, Inc.

Completed

Open Label Study for the Evaluation of Tolerability of Five Dose Levels of Cand5

Macular Degeneration

United States
OPKO Health, Inc.

Withdrawn

Safety & Efficacy Study Evaluating the Combination of Bevasiranib & Lucentis Therapy in Wet AMD (CARBON) (CARBON)

Age Related Macular Degeneration
OPKO Health, Inc.

Terminated

Safety & Efficacy Study Evaluating the Combination of Bevasiranib & Lucentis Therapy in Wet AMD (COBALT)

Macular Degeneration

United States, Canada

3

Subscribe